title: Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer.
abstract: OBJECTIVE
  Both hepatic steatosis (HS) and colorectal cancer (CRC) are conditions associated with metabolic syndrome. The liver is the most frequent site of distant metastasis of CRC; however, the impact of HS on the incidence of liver metastasis of CRC is not clearly defined. Then, the correlation with the presence or absence of HS was analyzed.
  
  
  METHODS
  A total of 604 CRC patients receiving curative surgical resection who had a preoperative non-enhanced computed tomography (CT) were enrolled. The mean attenuation values (in Hounsfield units) of the liver and spleen were obtained on a plain CT slice, and the patients with liver-spleen attenuation ratio lower than 1.1 were objectively defined as HS. The clinicopathological features of these patients were analyzed, and the association between HS and the clinical features of CRC was examined.
  
  
  RESULTS
  Sixty-three (10.4%) among the 604 patients were diagnosed as HS. Recurrence-free survival (RFS) and hepatic RFS, but not extrahepatic RFS, were significantly higher in the group with HS (p = 0.04 and p = 0.006). However, this effect was not evident in the group of patients with obesity, defined as body mass index > 25.0. Among the stage I~III cases, HS was significantly associated with lower hepatic, but not extrahepatic, RFS. Moreover, absence of HS was an independent risk factor for hepatic RFS (p = 0.003).
  
  
  CONCLUSIONS
  Metastases of CRC are less frequent in fatty liver. Steatosis may be an unfavorable microenvironment for metastatic formation in the liver.
authors: Division of Surgical Oncology, Department of Surgery, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. MURONOK-SUR@h.u-tokyo.ac.jp
authors: Koji
authors: K
authors: Murono
authors: Joji
authors: J
authors: Kitayama
authors: Nelson H
authors: NH
authors: Tsuno
authors: Hiroaki
authors: H
authors: Nozawa
authors: Kazushige
authors: K
authors: Kawai
authors: Eiji
authors: E
authors: Sunami
authors: Masaaki
authors: M
authors: Akahane
authors: Toshiaki
authors: T
authors: Watanabe
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism; D015179:Colorectal Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D018572:Disease-Free Survival; D005234:Fatty Liver / Q000150:complications* / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008113:Liver Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000556:secondary* / Q000601:surgery; D008297:Male; D015999:Multivariate Analysis; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009367:Neoplasm Staging; D009765:Obesity / Q000150:complications; D011379:Prognosis; D011859:Radiography; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor
references: World J Gastroenterol. 2011 Feb 14;17(6):804-8
references: 21390153
references: Ann Surg Oncol. 2009 Apr;16(4):1043-50
references: 19165543
references: AJR Am J Roentgenol. 2010 Mar;194(3):623-8
references: 20173137
references: Int J Cancer. 2004 May 10;109(6):893-9
references: 15027123
references: Eur J Gastroenterol Hepatol. 2009 Jun;21(6):673-80
references: 19318971
references: World J Gastroenterol. 2011 Jul 14;17(26):3092-100
references: 21912451
references: J Gastroenterol Hepatol. 2008 Jun;23(6):894-9
references: 18565021
references: Hepatogastroenterology. 1997 Jul-Aug;44(16):1069-75
references: 9261601
references: N Engl J Med. 2003 Apr 24;348(17):1625-38
references: 12711737
references: Diagn Interv Radiol. 2012 May-Jun;18(3):282-7
references: 22258794
references: Dig Dis Sci. 2011 Jul;56(7):2145-51
references: 21318585
references: Clin Exp Metastasis. 2008;25(2):171-81
references: 18058027
references: J Am Coll Surg. 2003 Jun;196(6):874-9
references: 12788423
references: CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36
references: 21685461
references: Eur J Immunol. 1999 Aug;29(8):2406-13
references: 10458753
references: Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):224-38
references: 21386810
references: Int J Cancer. 2011 Jun 1;128(11):2527-35
references: 21365651
references: N Engl J Med. 2002 Sep 5;347(10):768-9; author reply 768-9
references: 12214633
references: Am J Pathol. 2009 Jul;175(1):355-64
references: 19541928
references: Cancer Res. 1999 Oct 15;59(20):5102-5
references: 10537282
references: Surg Oncol. 2007 Jul;16(1):3-5
references: 17493802
references: J Hepatol. 2010 Apr;52(4):579-85
references: 20185194
references: Hepatogastroenterology. 2000 Nov-Dec;47(36):1541-5
references: 11148998
references: Apoptosis. 2010 May;15(5):621-30
references: 20107900
references: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references: 21296855
references: CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78
references: 19897840
references: Clin Exp Metastasis. 2011 Oct;28(7):675-88
references: 21739249
references: Hepatogastroenterology. 1999 Jan-Feb;46(25):167-71
references: 10228783
references: Eur J Nutr. 2007 Aug;46(5):279-85
references: 17593466
references: Lipids Health Dis. 2010 Oct 08;9:112
references: 20932327
references: Radiology. 2011 Mar;258(3):760-6
references: 21212369
references: Immunol Today. 2000 Nov;21(11):573-83
references: 11094262
references: Eur Radiol. 2012 May;22(5):1075-82
references: 22138733
references: Am J Surg. 1999 Apr;177(4):279-81
references: 10326842
references: Clin Sci (Lond). 2008 Apr;114(7):457-66
references: 18302533
references: Am J Surg. 1992 Aug;164(2):176-7
references: 1636899
references: AJR Am J Roentgenol. 2007 Dec;189(6):W320-3
references: 18029843
references: World J Gastroenterol. 2011 Apr 7;17(13):1725-31
references: 21483633